Dabur India in talks to acquire Paras Pharma; PE Fund Actis looking to exit Paras Pharma: Sources
Dabur India is in talks to acquire Paras Pharma, reports CNBC-TV18 quoting sources. PE Fund Actis is looking to exit Paras Pharma.
Actis currently holds almost 60% stake in Paras. Pharma player Paras sells Dermicool, Moov, Krack brands. Actis had first bought 23% stake in Paras for $ 43 million in 2006.
Sources said that the talks are at advanced stage level. Dabur first looked at Paras 6 months ago.
Dabur India said that the company cannot comment on market speculations. The company continues to look at acquisition opportunities.
Paras Pharma said that the company is not in talks with Dabur. It said that Actis is not looking to sell out its stake.
Source: Stock Market Today